Literature DB >> 20019753

Atrial fibrillation: Dronedarone and amiodarone-the safety versus efficacy debate.

Eric N Prystowsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20019753     DOI： 10.1038/nrcardio.2009.221

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  7 in total

1.  A comparison of rate control and rhythm control in patients with atrial fibrillation.

Authors:  D G Wyse; A L Waldo; J P DiMarco; M J Domanski; Y Rosenberg; E B Schron; J C Kellen; H L Greene; M C Mickel; J E Dalquist; S D Corley
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

2.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

3.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation).

Authors:  Valentin Fuster; Lars E Rydén; David S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; Jean-Yves Le Heuzey; G Neal Kay; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; Samuel Wann; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffery L Anderson; Elliott M Antman; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; José Luis Zamorano
Journal:  J Am Coll Cardiol       Date:  2006-08-15       Impact factor: 24.094

4.  Increased mortality after dronedarone therapy for severe heart failure.

Authors:  Lars Køber; Christian Torp-Pedersen; John J V McMurray; Ole Gøtzsche; Samuel Lévy; Harry Crijns; Jan Amlie; Jan Carlsen
Journal:  N Engl J Med       Date:  2008-06-19       Impact factor: 91.245

5.  Effect of dronedarone on cardiovascular events in atrial fibrillation.

Authors:  Stefan H Hohnloser; Harry J G M Crijns; Martin van Eickels; Christophe Gaudin; Richard L Page; Christian Torp-Pedersen; Stuart J Connolly
Journal:  N Engl J Med       Date:  2009-02-12       Impact factor: 91.245

6.  Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.

Authors:  Bramah N Singh; Stuart J Connolly; Harry J G M Crijns; Denis Roy; Peter R Kowey; Alessandro Capucci; David Radzik; Etienne M Aliot; Stefan H Hohnloser
Journal:  N Engl J Med       Date:  2007-09-06       Impact factor: 91.245

Review 7.  Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.

Authors:  Jonathan P Piccini; Vic Hasselblad; Eric D Peterson; Jeffrey B Washam; Robert M Califf; David F Kong
Journal:  J Am Coll Cardiol       Date:  2009-09-15       Impact factor: 24.094
  7 in total
  6 in total

1.  [Update hyperthyreoidism].

Authors:  L Möller; K Mann
Journal:  Internist (Berl)       Date:  2010-05       Impact factor: 0.743

2.  Acute dronedarone is inferior to amiodarone in terminating and preventing atrial fibrillation in canine atria.

Authors:  Alexander Burashnikov; Luiz Belardinelli; Charles Antzelevitch
Journal:  Heart Rhythm       Date:  2010-05-15       Impact factor: 6.343

Review 3.  The emerging role of amiodarone and dronedarone in Chagas disease.

Authors:  Gustavo Benaim; Alberto E Paniz Mondolfi
Journal:  Nat Rev Cardiol       Date:  2012-08-07       Impact factor: 32.419

4.  In vitro anti-Trypanosoma cruzi activity of dronedarone, a novel amiodarone derivative with an improved safety profile.

Authors:  Gustavo Benaim; Vanessa Hernandez-Rodriguez; Sheira Mujica-Gonzalez; Lourdes Plaza-Rojas; May Li Silva; Nereida Parra-Gimenez; Yael Garcia-Marchan; Alberto Paniz-Mondolfi; Graciela Uzcanga
Journal:  Antimicrob Agents Chemother       Date:  2012-04-16       Impact factor: 5.191

5.  Targeting isoprenoid biosynthesis for drug discovery: bench to bedside.

Authors:  Eric Oldfield
Journal:  Acc Chem Res       Date:  2010-09-21       Impact factor: 22.384

6.  A repurposing approach identifies off-patent drugs with fungicidal cryptococcal activity, a common structural chemotype, and pharmacological properties relevant to the treatment of cryptococcosis.

Authors:  Arielle Butts; Louis DiDone; Kristy Koselny; Bonnie K Baxter; Yeissa Chabrier-Rosello; Melanie Wellington; Damian J Krysan
Journal:  Eukaryot Cell       Date:  2012-12-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.